ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-OR32

Spatially Localized Mesangial Cell Communication in Diabetic Kidney Disease

Session Information

Category: Diabetic Kidney Disease

  • 701 Diabetic Kidney Disease: Basic

Authors

  • Melo Ferreira, Ricardo, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Phillips, Carrie L., Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Asghari, Mahla, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Gisch, Debora L., Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Barwinska, Daria, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Ferkowicz, Michael J., Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Sabo, Angela R., Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Lake, Blue, San Diego Institute of Science, Altos Labs, San Diego, California, United States
  • Sutton, Timothy A., Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Guo, Shunhua, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Cheng, Ying-Hua, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Alpers, Charles E., University of Washington, Seattle, Washington, United States
  • Jain, Sanjay, Washington University in St Louis School of Medicine, St Louis, Missouri, United States
  • El-Achkar, Tarek M., Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Dagher, Pierre C., Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Kelly, Katherine J., Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Eadon, Michael T., Indiana University School of Medicine, Indianapolis, Indiana, United States

Group or Team Name

  • KPMP.
Background

Substantial knowledge has been gained regarding podocyte injury in diabetic kidney disease (DKD) but less is known about the mechanisms of mesangial expansion, nodule formation, and its relationship with neovascularization. Changes in communication between injured cells serve as both a marker of disease progression and a mediator, promoting injury responses through positive feedback in surrounding cells. In this study, we aim to spatially localize changes in intra-glomerular communication between mesangial, endothelial, and epithelial cells.

Methods

We subsetted the KPMP / HuBMAP snRNAseq atlas into reference (N=11) and diabetic (N=7) samples. Using the CellChat database, we modelled cell-cell communication in glomerular cell types. The snRNAseq atlas was used as reference to deconvolute 23 kidney spatial transcriptomics samples, including reference (N=6) and diabetic (N=10). The modelled cell-cell communication and associated pathway vectors were then localized onto glomeruli with COMMOT.

Results

The cellular communication decreases in diabetic glomeruli (442) when compared to reference (1092). The overall loss of receptor-ligand interaction is more pronounced in diabetic mesangial cells, from 309 to 55 (p value < 10-9, Fisher’s Exact). Some of the communication absent in diabetic mesangial cells include the JAG1 - NOTCH interaction with glomerular capillaries and podocytes and the Gas6 – TAM, cell proliferation, angiogenesis and immune activation. Associated pathways were differentially represented in healthy control and DKD spatial transcriptomic samples.

Conclusion

These studies indicate a change in the intercellular communication in diabetic glomeruli. Identified pathways are potentially implicated in the process of neovascularization, mesangial expansion and glomerulosclerosis.

Funding

  • NIDDK Support